Koninklijke Philips N.V.

PHG Healthcare Medical Devices

Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024. In the quarter to June 2026, revenue grew 2.94%, EPS grew 56.7%, free cash flow grew 49.7% and total debt fell 9.93%, each against the same quarter a year earlier.

25.74 0.25 +0.98%
Market cap
$24.9B
P/E
18.8×
Fwd P/E
11.2×
Dividend yield
3.94%
F-score
7/9
Altman Z
1.98
Beneish M
−2.68
Dividend safety
55/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

33.65 24.87 22.85 19.86
P/S ratio
1.36 1.27 1.28 1.26
P/FCF ratio
0.00 44.24 14.78 14.05
P/Operating CF
71.24 16.23 118.50 59.63
P/B ratio
2.10 2.07 1.95 1.95
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
1.68 1.50 1.52 1.51
EV/EBITDA
11.16 10.50 10.26 9.19
EV/Operating CF
(93.09) 22.83 12.26 11.98
EV/FCF
(25.95) 52.15 17.59 16.85
Quick Ratio
0.76 0.86 0.80 0.73
Current Ratio
1.32 1.32 1.32 1.26
Net Debt/EBITDA
8.10 5.15 8.34 4.51
Debt/Assets
27.48% 25.73% 25.27% 23.65%
Debt/Equity
0.68 0.63 0.60 0.55
Asset Turnover
0.61 0.65 0.68 0.67
Operating CF/Net income
1.69 3.55 1.25 0.98
Capex/Depreciation
(0.51) (0.70) (0.60) (0.40)
Interest Coverage
4.22 4.94 2.90 6.42
Research and Development Expense of Revenue
9.62% 8.49% 10.09% 11.10%
Selling, General and Administrative Expense of Revenue
27.38% 25.81% 30.32% 27.68%
Intangible Assets out of Total Assets
0.45 0.44 0.45 0.46
Share Based Compensation of Revenue
0.80% 0.50% 0.77% 1.17%
Graham Net Nets
(0.29) (0.27) (0.27) (0.26)
Graham Number
15.40 17.92 19.46 20.74
Earnings Yield
2.97% 4.02% 4.38% 5.03%
Free Cash Flow Yield
(4.76%) 2.26% 6.76% 7.12%
Revenue per Share
5.29 6.23 4.80 5.31
Operating CF per Share
0.38 1.67 0.23 0.46
Capex per Share
(0.20) (0.21) (0.20) (0.18)
Free Cash Flow per Share
0.18 1.46 0.03 0.27
Cash per Share
2.45 3.43 3.28 2.25
Shareholders Equity per Share
13.01 13.11 14.04 13.96
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
13.01 13.11 14.04 13.96
Free Cash Flow
173.20 1,384.61 32.77 259.07
Working Capital
2,627.68 2,741.38 2,753.95 2,218.43
Capital Expenditures
(190.63) (197.38) (187.26) (176.66)
Net Current Asset Value
(7,573.31) (6,813.30) (7,097.31) (6,854.12)
EV/EBIT
23.31 18.79 17.93 15.71
Capex to Sales
0.04 0.03 0.04 0.03
Price to Operating Income
18.85 15.94 15.07 13.10
Other line items
Average Receivables
4,048.70 4,150.20 3,766.77 3,979.52
Average Payables
1,898.56 2,086.24 2,128.50 3,010.77
Average Inventory
4,137.90 3,568.44 3,574.58 3,704.10
Average Assets
31,480.50 31,112.50 30,266.28 30,495.35
Average Common Equity
12,815.45 12,633.70 12,858.43 12,580.31

Fold the line items

Columns are period end dates